Wockhardt | Compliance Alerts | Radio Compass News

Enforcement Report - Week of November 1, 2017

01 Nov 2017 //

FDA

Wockhardt Subsidiary Morton Grove Receives FDA Warning Letter

07 Mar 2017 //

FDA

FDA Issues Form 483 to Wockhardt Limited

26 Jan 2017 //

FDA

Wockhardt Limited Recievs FDA Warning Letter

23 Dec 2016 //

FDA

CP Pharmaceuticals Recievs FDA Warning Letter

16 Nov 2016 //

FDA

Wockhardt Limited On FDA Import Alert List

28 Sep 2016 //

FDA

Wockhardt Limited On Health Canada Inspection List

20 Sep 2016 //

HEALTH CANADA

Wockhardt Limited Placed On FDA Import Alert List

05 Aug 2016 //

FDA

Wockhardt gets US FDA report with `observations`

21 Jul 2016 //

BUSINESS STANDARD

Wockhardt Usa Inc. recalls Lisinopril Tablets USP, 5 mg due to CGMP Deviations

29 Aug 2015 //

FDA

Recalls of product made at Wockhardt due to CGMP deviations

03 Aug 2015 //

FDA

Class II recall of Captopril Tablets, USP 12.5 mg by Wockhardt USA Inc.

13 May 2015 //

FDA

U.K. regulators find issues with Indian-owned API distributor Relonchem

06 May 2015 //

FIERCE PHARMA MANUFACTURING

FDA 483 Citations for Waluj Plant of Wockhardt Reveal that Serious GMP Issues Still Persist

26 Feb 2015 //

DRUG REGULATIONS

U.K. Expands Wockhardt Ban

21 Jan 2015 //